Home » Topics » Conferences

Conferences
RSS

PEG-rhSOD advancing in preclinical phase

April 5, 1996

Spartaject busulfan to enter phase I

April 5, 1996

Virend entering phase III

April 5, 1996

BILD-1351 for HSV infection

April 5, 1996

New 5alpha-reductase inhibitor from Merck & Co.

March 26, 1996

Multidrug resistance modulator from Pfizer

March 15, 1996

Xenova to evaluate MDR modulator in phase I

March 15, 1996

Eisai describes antitumor sulfonamide

March 15, 1996

OM-174 shows in vivo antitumor activity

March 15, 1996

IDEC-C2B8 development update

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 22, 2025.
Biopharma restructurings reflect strategy of short-term pain for long-term gains
BioWorld
Ongoing restructurings in the biopharma sector show common themes of cost-cutting, clinical failures and shifting strategic priorities. Companies are increasingly...
Field Medical harvests $40M for PFA system
BioWorld MedTech
Field Medical Inc. reaped $40 million in its series A fundraising via $20 million in new capital and conversion of $20 million in seed-round debt to support...
Roche follows other pharmas, committing $50B in US investment
BioWorld
Roche AG has become the latest pharmaceutical company to respond to the Trump administration’s threat to impose tariffs, saying it will invest $50 billion in drug...